Volkan Aydin (Volkan Aydın)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Cervical Cancer Screening

Anti Inflammatory Drugs

Top Venues

Turkish journal of medical sciences

Primary health care research & development

Advances in experimental medicine and biology

Postgraduate medical journal

This page only lists publications with an associated author ORCID identifier.

Publications

Ferit Bayram, Sabire Senem Kilic, Volkan Aydin, Ahmet Akici, Korkut Ulucan, Tunç Akkoç
Medication-Related Osteonecrosis of the Jaw: Bibliometric Analysis from 2003 to 2023. Advances in experimental medicine and biology (2024)
Onur Gultekin, Volkan Aydin, Dilara Bayram, Ömer Ataç, Ahmet Akici
Pharmacoeconomic implications of preference toward reference- versus generic-brand antidepressants in primary care. Primary health care research & development 25 (2024)
N. İpek Kırmızı, Volkan Aydin, Omer Atac, Ahmet Akici
Association of arbitrary prescribing behavior to costly drug expenditures: a pharmacoeconomic study in primary care. Postgraduate medical journal (2023)
Dilara Bayram, Caner Vizdiklar, Volkan Aydin, Narin Akıcı, Ömer Ataç, Ahmet Akici
Supratherapeutic utilization of paracetamol versus ibuprofen among <12-year-old children in primary care in Istanbul. Family practice (2023)
Ömer Ataç, Volkan Aydin, Selma Karabey, Osman Hayran, Ahmet Akici
Good versus poor prescribers: the comparison of prescribing competencies in primary care. Primary health care research & development 23 (2022)
N. İpek Kırmızı, Volkan Aydin, Narin Akıcı, Banu Bayar, Ahmet Akici
Utilization of biotechnological drugs in rare diseases requiring the use of off-label drugs in children in Turkey Turkish journal of medical sciences 51 (4) (2021)
Volkan Aydin, Ahmet Akici, Sibel Sakarya, Mehmet Akman, Ali Serdar Fak
Baseline characteristics predicting clinical outcomes and serious adverse events in middle-aged hypertensive women: a subanalysis of the SPRINT in women aged <65 years Turkish journal of medical sciences 50 (5) (2020)